Press Release: New recommendations to manage risk of allergic reactions with intravenous iron-containing medicines

Author (Corporate)
Series Title
Series Details EMA/377372/2013 (28.06.13)
Publication Date 28/06/2013
Content Type

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP), in June 2013, completed its review of intravenous iron-containing medicines used to treat iron deficiency and anaemia (low red blood cell counts) associated with low iron levels. The CHMP concluded that the benefits of these medicines were greater than their risks, provided that adequate measures were taken to minimise the risk of allergic reactions.
Source Link http://www.emea.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/06/news_detail_001833.jsp&mid=WC0b01ac058004d5c1
Related Links
EMA: Press Release: EMA/377372/2013 (28.06.13) http://www.emea.europa.eu/docs/en_GB/document_library/Press_release/2013/06/WC500144874.pdf
Subject Categories
Countries / Regions